Federal Register - February 4, 2021
Versión en texto ¿Qué es?Dateas es un sitio independiente no afiliado a entidades gubernamentales. La fuente de los documentos PDF aquí publicados es la entidad gubernamental indicada en cada uno de ellos. Las versiones en texto son transcripciones no oficiales que realizamos para facilitar el acceso y la búsqueda de información, pero pueden contener errores o no estar completas.
Fuente: Federal Register
8204
Federal Register / Vol. 86, No. 22 / Thursday, February 4, 2021 / Notices
would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Library of Medicine Special Emphasis Panel; G08.
Date: March 26, 2021.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Video Assisted Meeting.
Contact Person: Leonid V. Tsap, Ph.D., Scientific Review Officer, Extramural Programs, National Library of Medicine, NIH, 6705 Rockledge Drive, Suite 500, Bethesda, MD 208927968, 3018277077, tsapl@
mail.nih.gov.
Catalogue of Federal Domestic Assistance Program No. 93.879, Medical Library Assistance, National Institutes of Health, HHS
Dated: January 26, 2021.
Ronald J. Livingston, Jr., Program Analyst, Office of Federal Advisory Committee Policy.
FR Doc. 202102278 Filed 2321; 8:45 am BILLING CODE 414001P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health National Cancer Institute; Notice of Closed Meetings
jbell on DSKJLSW7X2PROD with NOTICES
Pursuant to section 10d of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the provisions set forth in sections 552bc4 and 552bc6, Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis Panel; SEP2:
Research Answers to NCI Provocative Questions.
Date: February 23, 2021.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W104, Rockville, Maryland 20850
Telephone Conference Call.
Contact Person: David G. Ransom, Ph.D., Chief, Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W104, Rockville, Maryland 20850, 2402766351, david.ransom@nih.gov.
VerDate Sep<11>2014
17:13 Feb 03, 2021
Jkt 253001
Name of Committee: National Cancer Institute Special Emphasis Panel; NCI SPORE
P50 Review V.
Date: February 2526, 2021.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W120, Rockville, Maryland 20850
Telephone Conference Call.
Contact Person: Majed M. Hamawy, Ph.D., Scientific Review Officer, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W120, Rockville, Maryland 20850, 2402766457, mh101v@nih.gov.
Name of Committee: National Cancer Institute Special Emphasis Panel;
Visualization Methods and Tools Development for Enhancing Cancer Moonshot Data R33.
Date: March 10, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W108, Rockville, Maryland 20850
Telephone Conference Call.
Contact Person: Clifford W. Schweinfest, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W108, Rockville, Maryland 20850, 2402766343, schweinfestcw@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis Panel; SEP7: NCI
Clinical and Translational R21 and Omnibus R03 Review.
Date: March 1617, 2021.
Time: 9:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W104, Rockville, Maryland 20850
Telephone Conference Call.
Contact Person: David G. Ransom, Ph.D., Chief, Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W104, Rockville, Maryland 20850, 2402766351, david.ransom@nih.gov.
Name of Committee: National Cancer Institute Special Emphasis Panel; 3D
Technologies to Accelerate HTAN.
Date: March 19, 2021.
Time: 9:30 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W556, Rockville, Maryland 20850
Telephone Conference Call.
Contact Person: Kamal Datta, M.D., Scientific Review Officer, Program Coordination and Referral Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W556, Rockville, Maryland 20850, 2402766526, kamal.datta@nih.gov.
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
Name of Committee: National Cancer Institute Special Emphasis Panel; R01IARC
Conference Grant Review.
Date: April 6, 2021.
Time: 1:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W552, Rockville, Maryland 20850
Telephone Conference Call.
Contact Person: Jeanette Irene Marketon, Ph.D., Scientific Review Officer, Program Coordination and Referral Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W552, Rockville, Maryland 20850, 2402766780, jeanette.marketon@nih.gov.
Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS
Dated: January 26, 2021.
Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy.
FR Doc. 202102289 Filed 2321; 8:45 am BILLING CODE 414001P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health National Cancer Institute; Notice of Meeting Pursuant to section 10a of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Cancer Institute Council of Research Advocates.
The meeting will be held as a virtual meeting and is open to the public.
Individuals who plan to view the virtual meeting and need special assistance or other reasonable accommodations to view the meeting, should notify the Contact Person listed below in advance of the meeting. The meeting will be videocast and can be accessed from the NIH Videocasting and Podcasting website http videocast.nih.gov.
Name of Committee: National Cancer Institute Council of Research Advocates.
Date: March 1011, 2021.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: Welcome and Chairwomans Remarks, NCI Updates, Legislative Update, and Directors Update.
Place: National Institutes of Health, 9000
Rockville Pike, Building 31, Bethesda, MD
20892 Virtual Meeting.
Contact Person: Amy Williams, NCI Office of Advocacy Relations, National Cancer
E:FRFM04FEN1.SGM
04FEN1
